Cepheid

Most Recent

  • uploads///part a
    Earnings Report

    Why Danaher Is Relatively Immune from Growth Concerns in China

    Organically, Danaher (DGR) has grown at a CAGR of roughly 10% in China over the last five years. Approximately 50% of the company’s revenues in China are derived from its Diagnostics segment.

    By Shannon Black
  • uploads///margin estimates
    Earnings Report

    A Look at Danaher’s 4Q16 Margin Estimates

    In 4Q15, Danaher’s (DHR) adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) was ~$1.4 billion, while its EBITDA margin was 23.3%.

    By Sheldon Krieger
  • uploads///danaher acquires cepheid
    Healthcare

    How Cepheid Fits Strategically into DHR’s Portfolio

    The acquisition of Cepheid (CPHD) in the strategic sense is a gateway for Danaher (DHR) to breathe life into its limited molecular testing capabilities.

    By Shannon Black
  • uploads///danaher acquires cepheid
    Healthcare

    DHR to Reap $200 Million in Cost Synergies, Revenue through Buy

    Danaher (DHR) says it has identified $100 million in cost synergies and another $100 million in revenues over the next five years.

    By Shannon Black
  • uploads///danaher acquires cepheid
    Healthcare

    What Made Cepheid Attractive to Danaher?

    On September 6, 2016, Danaher (DHR) announced that it has entered into a definitive agreement to acquire Cepheid (CPHD) for $4 billion.

    By Shannon Black
  • uploads///cphd pm
    Earnings Report

    Cepheid’s Revenue and Income Fell in 3Q15

    After its 3Q15 earnings report, Cepheid fell by 0.86% to close at $32.25 per share as of October 20, 2015, with a 4.8% fall in revenue in 3Q15.

    By Gabriel Kane
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.